Myung In Pharmaceutical LTD. (KRX:317450)

KRX:317450 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.02	0.03	0.04	0.06	0.07	0.09
Debt / FCF Ratio	0.03	0.04	0.05	0.09	0.09	0.15
Asset Turnover	-	0.49	0.49	0.50	0.52	0.52
Inventory Turnover	-	1.73	1.70	1.74	1.56	1.78
Quick Ratio	7.33	7.28	6.37	5.76	4.52	3.53
Current Ratio	8.63	8.65	7.85	7.15	5.71	4.73
Return on Equity (ROE)	-	13.68%	16.63%	14.36%	16.91%	14.37%
Return on Assets (ROA)	-	10.51%	10.52%	10.53%	11.41%	11.17%
Return on Capital (ROIC)	-	11.47%	11.55%	11.70%	12.90%	12.66%
Return on Capital Employed (ROCE)	16.30%	17.30%	17.30%	17.40%	19.00%	18.80%
Payout Ratio	14.37%	8.15%	30.06%	19.50%	23.43%	43.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.